A2PU44
Gene name |
A51_B1772 |
Protein name |
NAD(+)--arginine ADP-ribosyltransferase Chelt |
Names |
Putative mono(ADP-ribosyl)transferase, mADPRT, mART, Toxin Chelt |
Species |
Vibrio cholerae |
KEGG Pathway |
|
EC number |
2.4.2.31: Pentosyltransferases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for A2PU44
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-A2PU44-F1 | Predicted | AlphaFoldDB |
No variants for A2PU44
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for A2PU44 | |||||
No associated diseases with A2PU44
4 regional properties for A2PU44
Functions
| Description | ||
|---|---|---|
| EC Number | 2.4.2.31 | Pentosyltransferases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| extracellular space | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| NAD+-protein-arginine ADP-ribosyltransferase activity | Catalysis of the reaction: L-arginyl- + NAD+ = H+ + (ADP-D-ribosyl)-L-arginyl- |
| nucleotide binding | Binding to a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| nucleotidyltransferase activity | Catalysis of the transfer of a nucleotidyl group to a reactant. |
| toxin activity | Interacting selectively with one or more biological molecules in another (target) organism, initiating pathogenesis (leading to an abnormal, generally detrimental state) in the target organism. The activity should refer to an evolved function of the active gene product, i.e. one that was selected for. Examples include the activity of botulinum toxin, and snake venom. |
No GO annotations of biological process
| Name | Definition |
|---|---|
| No GO annotations for biological process |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MKTIISLIFI | MFPLFVSAHN | GNFYRADSRS | PNEIKDLGGL | YPRGYYDFFE | RGTPMSISLY |
| 70 | 80 | 90 | 100 | 110 | 120 |
| DHARGAPSGN | TRYDDGFVST | TTDIDSAHEI | GQNILSGYTE | YYIYLIAPAP | NLLDVNAVLG |
| 130 | 140 | 150 | 160 | 170 | 180 |
| RYSPHPQENE | YSALGGIPWT | QVIGWYVVNN | GVLDRNIHRN | RQFRADLFNN | LSPALPSESY |
| 190 | 200 | 210 | 220 | 230 | 240 |
| QFAGFEPEHP | AWRQEPWINF | APPGCGRNVR | LTKHINQQDC | SNSQEELVYK | KLQDLRTQFK |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VDKKLKLVNK | TSSNNIIFPN | HDFIREWVDL | DGNGDLSYCG | FTVDSDGSRK | RIVCAHNNGN |
| 310 | 320 | 330 | 340 | 350 | 360 |
| FTYSSINISL | SDYGWPKGQR | FIDANGDGLV | DYCRVQYVWT | HLYCSLSLPG | QYFSLDKDAG |
| 370 | 380 | 390 | 400 | 410 | 420 |
| YLDAGYNNSR | AWAKVIGTNK | YSFCRLTSNG | YICTDIDSYS | TAFKDDDQGW | ADSRYWMDID |
| 430 | 440 | 450 | 460 | 470 | 480 |
| GNGGDDYCRL | VYNWTHLRCN | LQGKDGLWKR | VESKYLDGGY | PSLRFKIKMT | SNKDNYCRIV |
| 490 | 500 | 510 | 520 | 530 | 540 |
| RNHRVMECAY | VSDNGEFHNY | SLNMPFSLYN | KNDIQFIDID | GDNRDDICRY | NSAPNTMECY |
| 550 | 560 | 570 | 580 | 590 | 600 |
| LNQDKSFSQN | KLVLYLSAKP | ISSLGSGSSK | IIRTFNSEKN | SSAYCYNAGY | GTLRCDEFVI |
| Y |